3-Oxo-3-o-tolyl-propionic acid ethyl ester, 95.0%, 1g

3-(Methylamino)benzoic acid hydrochloride, 95.0%, 1g

1-(4-(tert-butyl)phenoxy)-3-(isopropylamino)propan-2-ol hydrochloride, 95.0%, 500mg

(2E)-1-(4-fluorophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 10g

N-(2-aminophenyl)methanesulfonamide, 95.0%, 10g

C-Isoxazol-5-ylmethanamine hydrochloride, 95.0%, 250mg

4-(4,5-DIPHENYL-1H-IMIDAZOL-2-YL)BENZOIC ACID, 98%, 100g

(R)-5,5-Dimethyl-4-phenyloxazolidin-2-one, 95.0%, 1g

2,3,5,6-Tetrafluoroterephthalaldehyde>98.0%(GC)5g

2-Chloro-N-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)benzamide, 98%, 50mg

2-(Hex-5-ynamido)acetic acid, 1g

1-[4-(prop-2-yn-1-yloxy)phenyl]ethan-1-ol, 95%, 250mg

monoclonal de souris anti-EP-CAM, HEA125, 0,2 ml